Penumbra, Inc Pay versus Performance
The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.
- 2025-12-31: PEO Adam Elsesser; PEO total compensation $851.62K; PEO compensation actually paid $851.62K; Other NEO average total compensation $2.85M.
- 2024-12-31: PEO total compensation $630.47K; PEO compensation actually paid $630.47K; Other NEO average total compensation $1.84M.
- 2023-12-31: PEO total compensation $601.62K; PEO compensation actually paid $601.62K; Other NEO average total compensation $622.62K.
- 2022-12-31: PEO total compensation $601.62K; PEO compensation actually paid $601.62K; Other NEO average total compensation $1.78M.
| Fiscal year end | PEO | PEO total compensation | PEO compensation actually paid | Other NEO average total compensation | Other NEO average compensation actually paid | Total shareholder return | Peer group total shareholder return | Net income | Company-selected measure | Proxy filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Adam Elsesser | $851.62K | $851.62K | $2.85M | $3.68M | $177.66 | $77.66 | $177.69M | revenue $1.40B | 2026-04-29 |
| 2024-12-31 | $630.47K | $630.47K | $1.84M | $1.79M | $135.70 | $77.83 | $14.01M | $1.19B | 2026-04-29 | |
| 2023-12-31 | $601.62K | $601.62K | $622.62K | $978.02K | $143.74 | $74.07 | $90.95M | $1.06B | 2026-04-29 | |
| 2022-12-31 | $601.62K | $601.62K | $1.78M | $1.06M | $127.12 | $78.99 | -$2.00M | $847.13M | 2026-04-29 | |
| 2021-12-31 | $497.79K | $497.79K | $1.31M | $1.97M | $164.18 | $103.04 | $5.28M | $747.59M | 2026-04-29 | |
| 2024-12-31 | Adam Elsesser | $630.47K | $630.47K | $1.84M | $1.79M | $144.57 | $103.45 | $14.01M | revenue $1.19B | 2025-04-16 |
| 2023-12-31 | $601.62K | $601.62K | $622.62K | $978.02K | $153.13 | $98.45 | $90.95M | $1.06B | 2025-04-16 | |
| 2022-12-31 | $601.62K | $601.62K | $1.78M | $1.06M | $135.42 | $104.99 | -$2.00M | $847.13M | 2025-04-16 | |
| 2021-12-31 | $497.79K | $497.79K | $1.31M | $1.97M | $174.91 | $136.96 | $5.28M | $747.59M | 2025-04-16 | |
| 2020-12-31 | $219.03K | $219.03K | $475.77K | $579.70K | $106.53 | $132.91 | -$15.70M | $560.41M | 2025-04-16 | |
| 2023-12-31 | Adam Elsesser | $601.62K | $601.62K | $622.62K | $978.02K | $205.84 | $120.41 | $90.95M | revenue $1.06B | 2024-04-24 |
| 2022-12-31 | $601.62K | $601.62K | $1.78M | $1.06M | $135.42 | $104.99 | -$2.00M | $847.13M | 2024-04-24 | |
| 2021-12-31 | $497.79K | $497.79K | $1.31M | $1.97M | $174.91 | $136.96 | $5.28M | $747.59M | 2024-04-24 | |
| 2020-12-31 | $219.03K | $219.03K | $475.77K | $579.70K | $106.53 | $132.91 | -$15.70M | $560.41M | 2024-04-24 | |
| 2022-12-31 | Adam Elsesser | $601.62K | $601.62K | $1.78M | $1.06M | $135.42 | $104.99 | -$2.00M | 2023-04-19 | |
| 2021-12-31 | $497.79K | $497.79K | $1.31M | $1.97M | $174.91 | $136.96 | $5.28M | 2023-04-19 | ||
| 2020-12-31 | $219.03K | $219.03K | $475.77K | $579.70K | $106.53 | $132.91 | -$15.70M | 2023-04-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |